Fzd7 was upregulated in hepatocellular carcinoma (HCC), resulting in activation of β-catenin pathway, accompanied by increased TCF transcriptional activity and cell proliferation rate [4–6]. The gene discussed is HNF4A; the disease is hepatocellular carcinoma.